Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03261102
NA

TDM Guided Early Optimization of ADAL in Crohn's Disease

Sponsor: waqqas.afif

View on ClinicalTrials.gov

Summary

To investigate the influence of early therapeutic drug monitoring and dose optimization on disease outcome in Crohn's patients treated with Adalimumab.

Official title: Therapeutic Drug Monitoring Guided Early Optimization of Adalimumab in Crohn's Disease; A Randomized Open Label Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

200

Start Date

2017-01-17

Completion Date

2025-06-01

Last Updated

2025-05-25

Healthy Volunteers

No

Interventions

BIOLOGICAL

Adalimumab

Locations (6)

University of Calgary Medical Center (UCMC)

Calgary, Alberta, Canada

The University of British Columbia

Vancouver, British Columbia, Canada

London Health Sciences Centre (LHSC) University Hospital

London, Ontario, Canada

The Ottawa Hospital, IBD Centre of Excellence

Ottawa, Ontario, Canada

McGill University Hospital Center (MUHC)

Montreal, Quebec, Canada

Centre Hospitalier Universitaire de Sherbrooke (CHUS)

Sherbrooke, Quebec, Canada